Kernal Biologics has been awarded $48 million from ARPA-H to develop in vivo CAR T-cell therapies for hematological cancers. This funding is part of ARPA-H’s EMBODY program, aimed at enhancing immune cell engineering.
Amount Raised
$48 Million
Round Type
Funding Round
CambridgeBiotechnologyHealthcareHealth CareresearchInvestors
Description
Kernal Biologics, Inc. has secured up to $48 million in funding from ARPA-H to advance its in vivo mRNA-encoded CAR T-cell program, KR-402. This initiative targets multiple sclerosis and various B-cell malignancies. Collaboration with Stanford University School of Medicine and others will support the project's development
Quick answer
Kernal Biologics raised $48 Million in a Funding Round round, dated October 7, 2025. Investors: Arpa H. Kernal Biologics is based in Cambridge, Massachusetts, United States.
- How much did Kernal Biologics raise?
- Kernal Biologics raised $48 Million in a Funding Round round on October 7, 2025.
- Who invested in Kernal Biologics?
- Arpa H is named as investors in this round.
- What does Kernal Biologics do?
- Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology.
- Where is Kernal Biologics based and how big is it?
- Kernal Biologics is based in Cambridge, Massachusetts, United States. Fundz records about 15 employees.
- Who are the decision-makers at Kernal Biologics?
- Fundz holds 1 contact at Kernal Biologics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and research around the same time
Companies in the same sectors as Kernal Biologics that raised within 45 days of this round, from Fundz verified event records.
- Aarvik Therapeutics raised an undisclosed amount (Seed) on September 29, 2025.
- ClearPoint Neuro raised $18M on November 20, 2025.
- Damora Therapeutics, Inc. raised $285M on November 12, 2025.
- Nanoviricides raised $6M on November 12, 2025.
- Allurion Technologies raised $5M (Private Equity) on November 11, 2025.
- Tenon Medical raised $2.9M (Funding Round) on November 11, 2025.
Who to call at Kernal Biologics, and when
A new round usually means Kernal Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Kernal Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kernal Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kernal Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kernal Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kernal Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.